AGM Statement

By

Regulatory News | 13 Nov, 2019

Updated : 17:01

RNS Number : 3338T
JPMorgan Emerging Mkts Invest Trust
13 November 2019
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN EMERGING MARKETS INVESTMENT TRUST PLC

 

RESULTS OF ANNUAL GENERAL MEETING

 

Legal Entity Identifier: 5493001VPQDYH1SSSR77

Information disclosed in accordance with LR 9.6.18

 

Following the Annual General Meeting of the Company, which was held today, the Board is pleased to announce that all of the Ordinary Business put to shareholders was voted on by poll and passed. In addition, the following three items of special business was also voted on by poll and passed which:

 

i)          will allow the Company to allot new shares up to an aggregate nominal amount of £1,516,356, representing 5% of the Company's issued share capital;

 

ii)         will allow the disapplication of pre-emption rights on the allotment of new Ordinary shares and by way of a sale of Treasury shares; and

 

iii)        will allow the Company to make market purchases of up to  18,184,135 Ordinary shares representing 14.99% of the Company's issued share capital (excluding shares held in Treasury).

The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism which can be located at www.morningstar.co.uk/uk/NSM and from the Company's website, www.jpmemergingmarkets.co.uk 

The full results of the polls conducted at today's meeting will shortly be available on the Company's website.

 

 

13th November 2019

 

For further information, please contact:

Jonathan Latter

For and on behalf of

JPMorgan Funds Limited, Secretary

020 7742 4000


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMCKNDPABDDBDD

Last news